While tissue-specific suppression of LPCAT3 expression has been shown to confer resistance to weight gain in preclinical models, our research reveals a potential negative trend between serum LPCAT3 levels and obesity-related anthropometric measures. This evidence concerns the gene LPCAT3 and obesity disorder.